Top Stories
-
Researchers in Columbia's medical and engineering schools have edited a strain of non-pathogenic bacteria to colonize solid tumors in mice and safely deliver potent immunotherapies.
-
Barring ovarian cancer surgery at low-volume hospitals could limit access to care for many rural and underserved patients, a new study has found.
Topic
-
At Columbia, patients with brain cancer will be able to participate in a new type of clinical trial that promises to speed up the development of better drugs for glioblastoma.
Topic
-
Leading physician and researcher, Lisa Kachnic, MD, will lead Columbia's department of radiation oncology.
Topic
Latest News
- January 8, 2015
By tracing cancers back to their cells of origin, Columbia researchers are learning why some cancers become aggressive.
Topic
- December 17, 2014
The new treatment for basal cell nevus syndrome, also called Gorlin syndrome, springs from an unlikely location: Idaho’s mountain pastures.
Topic
- December 8, 2014
Richard D. Carvajal, MD, has been named director of the Experimental Therapeutics/Phase I program and melanoma service in medical oncology at NewYork-Presbyterian/Columbia University Medical Center, effective Nov. 1, 2014.
- November 19, 2014
Precision medicine for lung cancer is now allowing some patients to live for years with advanced disease, and better therapies are in the works.
Topic
- November 12, 2014
Daniel Seidman, author of “Smoke-Free in 30 Days,” will participate in a blogtalkradio show Nov. 17 in advance of this year’s Great American Smokeout on Nov. 20.
- October 27, 2014
A CUMC study found that the use of generic aromatase inhibitors, which cost considerably less than their brand-name counterparts, increased treatment adherence by 50 percent.
Topic
- October 9, 2014
Using an innovative algorithm, CUMC researchers have found that loss of a gene called KLHL9 is the driving force behind the most aggressive form of glioblastoma, the most common form of brain cancer.
Topic
- August 27, 2014
The Herbert Irving Comprehensive Cancer Center is one of only two NCI-designated Comprehensive Cancer Centers in New York City and one of only three in New York State.
Topic
- August 26, 2014
Columbia surgeons and radiation oncologists deliver precise radiotherapy immediately following cancer tumor removal.
Topic
- August 20, 2014
Research from Columbia shows that nerves play a critical role in stomach cancer growth and blocking nerve signals using surgery or Botox® could provide an effective therapy for the disease.
